This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Indivior PLC (NASDAQ:INDV) with a Buy rating and announced a price target of $28. Indivior shares closed at $21.80 on Tuesday. See how other analysts view this stock.
• DA Davidson analyst Griffin Bryan initiated coverage on Almonty Industries Inc. (NASDAQ:ALM) with a Buy rating and announced a price target of $7. Almonty shares closed at $4.15 on Tuesday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Douglas Tsao initiated coverage on Rapport Therapeutics, Inc. (NASDAQ:RAPP) with a Buy rating and announced a price target of $31. Rapport Therapeutics shares closed at $14.43 on Tuesday. See how other analysts view this stock.
• Raymond James analyst Ryan Deschner initiated coverage on Palvella Therapeutics, Inc. (NASDAQ:PVLA) with an Outperform rating and announced a price target of $54. Palvella Therapeutics shares closed at $37.52 on Tuesday. See how other analysts view this stock.
• Leerink Partners analyst Daina Graybosch initiated coverage on Adagene Inc. (NASDAQ:ADAG) with an Outperform rating and announced a price target of $7. Adagene shares closed at $1.8992 on Tuesday. See how other analysts view this stock.

Considering buying PVLA stock? Here’s what analysts think:

Read This Next:

• Top 2 Health Care Stocks You May Want To Dump In Q3

Photo via Shutterstock